Concepedia

E. Megan Flynn

EM

12

Publications

1.5K

Citations

12

H-Index

2003

Active since

Affiliations

Constellation Pharmaceuticals (United States)(Current)

WuXi AppTec (China)

University of Kentucky

E. Megan Flynn is an author at Constellation Pharmaceuticals (United States) specializing in medicine, molecular biology, and drug discovery.

Top concepts

Publications per year

2003–2018

12

Publications

12

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation

Ryan Raisner, Samir Kharbanda, Lingyan Jin et al. · Cell Reports · 2018 · 398 citations · Full text

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

Maia Vinogradova, Victor Gehling, Amy Gustafson et al. · Nature Chemical Biology · 2016 · 343 citations · Full text

, , +7

A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications

E. Megan Flynn, Oscar W. Huang, Florence Poy et al. · Structure · 2015 · 209 citations · Full text

, , +6

Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT

Raymond C. Trievel, E. Megan Flynn, Robert L. Houtz et al. · Nature Structural & Molecular Biology · 2003 · 130 citations

, , +5

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 117 citations · Full text

, , +17

Rows per page

1–5 of 12